EW logo

EW Edwards Lifesciences Corporation

New York Stock Exchange · Medical - Devices · Healthcare

$101.85
-2.03 (-1.95%)

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease p…

Market Cap: $58.56Bwww.edwards.com

Price

No data yet.

Social Signal Score

55
5d
50
1 mentions
—
30d
57
18 mentions
—
60d
56
24 mentions
—
90d
58
32 mentions
—
podcast: 1 · marketaux: 1 · rss: 10 · news: 15 · 4chan: 5

Analyst Ratings

49 analysts
Buyconsensus
Strong Buy 0Buy 34Hold 15Sell 0Strong Sell 0
Avg price target$109.2+7.2%
Low $100Median $110High $120
Current Consensus

Revenue

$1.72B+123.46%
$767.70M$1.09B$1.42B$1.74B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$2.60
$2.58–$2.62
22 analysts
FY2026
$3.02+16% YoY
$3.01–$3.06
17 analysts
FY2027
$3.41+13% YoY
$3.32–$3.49
17 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Bernard J. Zovighian
Sector
Healthcare
Industry
Medical - Devices
Employees
16,000
Beta
0.83
Country
US
Piotroski score
8 / 9 (Strong)
Altman Z-score
13.83
www.edwards.com